Evidence map›Paper›PMID 41877702›Full record

ArticleCyborg and bionic systems (Washington, D.C.)2026

RST2G: Residual-Guided Spatiotemporal Transformer Graph Fusion Enhancement for Breast Cancer Segmentation in DCE-MRI.

Shaoli Xie, Lulu Xu, Chenyi Lei, Jinxiang Wang, Jason Wang, Zhibin Wang, Yiran Sun, Danyi Li, Fangfang Li, Rubing Lin and 7 more

Abstract read
In one paragraph

Article in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shaoli XieDepartment of Thyroid and Breast Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China.
Lulu XuTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Chenyi LeiTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Jinxiang WangDepartment of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518107, China.
Jason WangTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Zhibin WangTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Yiran SunTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Danyi LiDepartment of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, China.
Fangfang LiDepartment of Surgical Anesthesia, Suining Central Hospital, Suining, Sichuan 629000, China.
Rubing LinDepartment of Orthopedics, Shenzhen Children's Hospital, Shenzhen, Guangdong 518000, China.
Hongwei YangDepartment of Breast and Thyroid Surgery, Suining Central Hospital, Suining, Sichuan 629000, China.
Yang XiaoTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Tianxu LvTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Yixuan HuangTsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Lingmi HouDepartment of Breast Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China.
Junyan LiDepartment of Thyroid and Breast Surgery, Chengdu Fifth People's Hospital, The Fifth People's Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Chengdu 611130, Sichuan, China.
Maoshan ChenDepartment of Breast and Thyroid Surgery, Suining Central Hospital, Suining, Sichuan 629000, China.ORCID https://orcid.org/0000-0002-6554-6210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate segmentation of breast tumors in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is essential for effective diagnosis, treatment planning, and monitoring of breast cancer. However, the high heterogeneity of tumor appearance and the complex spatiotemporal dynamics of contrast enhancement present critical challenges for existing segmentation methods. In this study, we propose a novel residual-guided spatiotemporal transformer with graph fusion enhancement (RST2G) framework for precise breast tumor segmentation in DCE-MRI. RST2G explicitly leverages pre-contrast MRI, post-contrast MRI, and their residual differences to capture rich inter-temporal kinetic information. Specifically, RST2G employs a weight-sharing hybrid encoder that combines convolutional neural networks and vision transformers to extract local and global features, followed by a residual-guided multi-scale refinement module to enhance feature discriminability. To effectively model spatial and temporal contextual dependencies, we construct modality-specific graphs and apply inter-slice and inter-temporal attention mechanisms for spatiotemporal graph enhancement. Extensive experiments on 2 publicly available breast DCE-MRI datasets demonstrate that RST2G significantly outperforms state-of-the-art 2-dimensional (2D), 3D, and 4D segmentation methods. Given its effectiveness in capturing complex spatiotemporal tumor characteristics for cancer annotation, RST2G has the potential to improve clinical breast cancer treatment.

Identifiers

PMID41877702
PMCPMC13006731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.